in Newswire May 9, 2022

SD Biosensor Facing Class Action After Voluntary Recall of Unapproved Standard Q At-Home COVID Tests

Cenci v. SD Biosensor USA, Inc.

Filed: May 6, 2022 § 1:22-cv-02613

A class action alleges the maker of the SDB Standard Q at-home covid test has failed to disclose that the tests are not authorized, cleared or approved for distribution in U.S. by the FDA.


New York

Last Updated on May 9, 2022 — 4:38 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.